Target intelligence / Profile preview

Fungal cell membrane phospholipid

Molecular classification
Other, Lipid, Membrane lipid, Glycerophospholipid
01

Overview

Fungal cell membrane phospholipids are a diverse group of amphipathic lipids forming the structural basis of the fungal plasma membrane. Each phospholipid molecule contains a hydrophilic head group (such as choline, ethanolamine, serine, or inositol) and two hydrophobic fatty acid tails. These molecules self-assemble into a bilayer that confers membrane integrity, selective permeability, and serves as a platform for various signaling and pathogenicity-related processes[1][2][3][4][5][7][8][10]. In fungi, phospholipids like phosphatidylcholine and phosphatidylethanolamine are indispensable for cell growth and virulence. Perturbations in phospholipid synthesis or direct interaction with these molecules can disrupt membrane function, leading to cell death. Targeting fungal cell membrane phospholipids, or the enzymes that create them, represents a promising antifungal strategy, yet selectivity and resistance remain therapeutic challenges.

Other names
Phospholipids (fungal)Membrane phospholipids (fungi)Glycerophospholipids (fungal)Fungal plasma membrane phospholipids
02

Mechanism of action

Direct interaction with membrane phospholipids, causing membrane collapse and cell death (mandimycin); Inhibition of phospholipid biosynthesis enzymes, resulting in incomplete membrane assembly; Perturbation of membrane integrity, enhancing cell susceptibility to stress and antifungals.

03

Biological functions

Membrane structure/integritySelective permeabilitySignal transductionCell growth and divisionEnvironmental adaptabilityPathogenicity/virulenceEnergy storage
04

Disease associations

InfectionOther (drug resistance, mycotoxin production, biofilm formation)
05

Safety considerations

Broad targeting may affect host cell membranes if not sufficiently selective for fungal pathwaysPotential for toxicity if drugs are not specific to fungal phospholipidsDrug resistance development is possible by adaptation of membrane composition or biosynthetic pathwaysChallenges in selectivity: Ensuring that drugs interact with fungal-specific molecules without targeting similar lipids in human cells
06

Interacting drugs

Mandimycin

3 more in the full profile.

07

Biomarkers

Phospholipid composition changes in fungal membranes (diagnostic marker for resistance or drug efficacy in research)Gene expression of biosynthetic enzymes (e.g., FgPsd2, FgCho2, FgOpi3 in Fusarium, potential research biomarkers)

Beyond the preview

Go deeper on Fungal cell membrane phospholipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell membrane phospholipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call